Amit Garg, MD

Amit Garg, MD, is a board-certified radiation oncologist at the M. D. Anderson Cancer Center Radiation Treatment Center at Presbyterian Kaseman Hospital.

He earned a graduate degree in biomedical ethics from Case Western Reserve University in Cleveland and trained at The University of Texas M. D. Anderson Cancer Center in Houston. He has authored several publications in the medical community in diverse areas including breast, prostate, lung, cervical, Hodgkins lymphoma, and esophageal cancers.

Dr. Garg's current area of research interest involves the treatment of cancer with a highly specialized type of radiation therapy called Stereotactic Radiation Therapy for lung tumors as well as metastatic disease in the brain, spine, and elsewhere.

Undergraduate Degree: B.A. Biology, Magna Cum Laude, Case Western Reserve University, Cleveland

Medical Degree: Baylor College of Medicine, Houston

Residency: The University of Texas M. D. Anderson Cancer Center, Houston

SELECTED PUBLICATIONS:

Garg AK, Nocebo Side Effects in Cancer Treatment. The Lancet Oncology, 2011 September 23, doi:10.1016/S1470-2045(11)70268-6. 

Garg AK and Bloom ES. Transitioning Breast Cancer Care from an Academic to Community Setting. Breast Diseases: A Year Book Quarterly 2011 2(2): 118-121.

Garg AK, Wang XS, Shiu AS, Allen P, Yang J, Mendoza T, Cleeland C, Rhines LD, Chang EL. Prospective Evaluation of Spinal Re-irradiation Using Stereotactic Body Radiation Therapy: The M.D. Anderson Cancer Center Experience. Cancer. 2011 Aug 1;117(15):3509-16.

Garg AK, Gopal R. Commentary on: Initial surgical experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi Lumen Balloon breast brachytherapy cathether. [Am Surg 75:1042-1049, 2009]. Breast Diseases: A Year Book Quarterly 21(2):175-176, 2010.  

Garg AK, Jhingran A, Klopp AH, Broaddus R, Aggarwal BB, Eifel PJ, Buchholz TA. Expression of Nuclear Transcription Factor Kappa B in Locally Advanced Human Cervical Cancer Treated With Definitive Chemoradiation. Int J Radiat Oncol Biol Phys. 2010 78(5):1331-6.

Castillo R, Castillo E, Guerra R, Johnson VE, McPhail T, Garg AK, Guerrero T. A framework for evaluation of deformable image registration spatial accuracy using large landmark point sets.  Phys Med Biol. 2009 Mar 5;54(7):1849-1870.

Garg AK, Frija E, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe W, Salehpour M, Buchholz TA. Effects of variable placement of the superior tangential/supraclavicular match line on dosimetric coverage of the level III axilla/axillary apex in patients treated with breast and supraclavicular radiation.  Int J Radiat Oncol Biol Phys. 2009 Feb. 1; 73(2):370-4.

Garg AK, Oh JL, Oswald MJ, Huang E, Strom EA, Perkins GH, Woodward WA, Yu TK, Tereffe W, Meric-Bernstam F, Hahn K, Buchholz TA. Effect of Postmastectomy Radiotherapy in Patients <35 Years Old with Stage II-III Breast Cancer Treated with Doxorubicin-Based Neoadjuvant Chemotherapy and Mastectomy. Int J Radiat Oncol Biol Phys. 2007 Dec 1; 69(5):1478-83.

Garg AK, Mai WY, McGary JE, Grant WH III, Butler EB, Teh BS. Radiation proctopathy in the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics 2006 Dec 1;66(5):1294-305.

Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M, Sahin AA.. The nuclear transcription factor kappa B (NF-B) and bcl-2 pathway correlates with pathological complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res, 2005 Dec 1;11(23):8398-402.

Garg AK, Buchholz TA, Aggarwal BB.  Chemosensitization and Radiosensitization of tumors by plant polyphenols.  Antioxidants and Redox Signaling 2005 Nov-Dec (12) 1630-1647.

Chandra A, Guerrero T, Liu H, Tucker SL, Zhongxing L, Stevens C, Chang JY, Melinda JD, O’Reilly M, Wang X, Murshed H, Garg AK, Bonnen MD, Mohan R, Cox JD, Komaki R. IMRT reduces lung irradiation in distal esophageal cancer over 3D-CRT. Radiotherapy and Oncology, 2005 Dec;77(3):247-53.

Woodward WA, Garg AK, Strom EA, Buchholz TA.  In Reply to Dr. Monsour, Letter to the editor. International Journal of Radiation Oncology Biology Physics, 2004 October 1; 60 (2): 687-88.

Garg AK and Buchholz TA. Commentary on: A prospective study of concurrent cyclophosphamide/methotrexate/5-FU and reduced-dose radiotherapy in patients with early-stage breast carcinoma.  Womens Oncology Review 2004; 4: 143-144.

Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary ES, Hunt KK, Schechter N, Sahin AA, Valero V, Tucker SL, Buchholz TA.. Clinical stage T3 disease or pathologic involvement of four or more lymph nodes predict for local-regional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiation. International Journal of Radiation Oncology Biology Physics, 2004 May 1; 59(1):138-45.

Younes A, Garg A, Aggarwal BB. Nuclear Transcription Factor-kappaB and Hodgkin’s Disease. Leukemia & Lymphoma, 2003 Jun 44 (6); 929–35.

Garg AK, Hortobagyi GN, Aggarwal BB, Sahin AA, Buchholz TA. Nuclear factor kappa B as a predictor of treatment response in breast cancer. Current Opinions in Oncology. 2003 November; 15(6): 405-11.

Garg AK, Aggarwal BB. Reactive Oxygen Intermediates in TNF signaling. Molecular Immunology. 2002 Dec;39(9):509-17.

Garg A, Aggarwal BB. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia. 2002 Jun;16(6):1053-68.

BOOK CHAPTERS:

Garg AK and Aggarwal BB. Chapter XIV: Nuclear transcription factor kappa B: A drug target for all seasons. Apoptotic pathways as targets for novel therapies in cancer and other diseases, edited by Los M and Gibson SB. 

Garg AK, Buchholz TA, and Aggarwal BB. Chapter 22 : Effects of Natural Polyphenols on Chemoradiotherapy in Cancer. Herbal Drugs: A Cancer Chemopreventive and Therapeutic Perspective. Ed(s) Sharma RK, Arora R. Jaypee Brothers Medical Publishers, 2010.